PFE Pfizer Inc.

Price (delayed)

$34.51

Market cap

$191.7B

P/E Ratio

12.15

Dividend/share

$1.48

EPS

$2.84

Enterprise value

$241.83B

Business Summary

Sector: Healthcare
Industry: Drug Manufacturers - General
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Highlights

The price to earnings (P/E) is 40% lower than the 5-year quarterly average of 20.1 and 13% lower than the last 4 quarters average of 14.0
Pfizer Inc's equity has increased by 11% YoY and by 3% QoQ
Pfizer Inc's EPS has increased by 43% YoY but it has decreased by 2.7% from the previous quarter
Pfizer Inc's net income has increased by 38% YoY but it has decreased by 3% QoQ
Pfizer Inc's revenue has decreased by 6% YoY and by 2.1% QoQ
Pfizer Inc's gross profit has decreased by 5% YoY and by 2.5% from the previous quarter

Key stats

Shares outstanding
5.55B
Market cap
$191.7B
Enterprise value
$241.83B
EBIT
$17.22B
EBITDA
$22.9B
Price to earnings (P/E)
12.15
Price to book (P/B)
2.94
Price to sales (P/S)
3.78
EV/EBIT
14.05
EV/EBITDA
10.56
Net debt/EBITDA
2.19
EV/Sales
4.77
EBITDA margin
45.2%
Gross margin
79.9%
Net margin
31.2%
Operating margin
18.1%
Return on assets
9.6%
Return on equity
25%
Return on invested capital
20%
Return on capital employed
13%
Return on sales
34%
Debt to equity
0.8
Free cash flow
$11.55B
Free cash flow per share
$2.08
Book value per share
$11.72
Revenue per share
$9.14
TBVPS
$13.23
Current ratio
1.03
Quick ratio
0.6
Working capital
$848M
Dividend yield
4.29%
DPS
$1.48
Payout ratio
52.1%

PFE stock price

Financial performance

PFE's net margin is up by 47% YoY
Pfizer Inc's net income has increased by 38% YoY but it has decreased by 3% QoQ
The operating income has contracted by 24% YoY and by 4.7% from the previous quarter
The company's operating margin fell by 19% YoY and by 2.2% QoQ

Valuation

Price to earnings (P/E)
Current price to earnings (P/E):
12.15
Pfizer Inc's EPS has increased by 43% YoY but it has decreased by 2.7% from the previous quarter
The price to earnings (P/E) is 40% lower than the 5-year quarterly average of 20.1 and 13% lower than the last 4 quarters average of 14.0
Price to book (P/B)
Current price to book (P/B):
2.94
PFE's P/B is 11% below its 5-year quarterly average of 3.3 and 11% below its last 4 quarters average of 3.3
Pfizer Inc's equity has increased by 11% YoY and by 3% QoQ
Price to sales (P/S)
Current price to sales (P/S):
3.78
PFE's P/S is 8% below its 5-year quarterly average of 4.1 and 6% below its last 4 quarters average of 4.0
Pfizer Inc's revenue has decreased by 6% YoY and by 2.1% QoQ

Efficiency

Pfizer Inc's ROS has soared by 52% YoY
The ROE rose by 44% YoY but it fell by 5% QoQ
Pfizer Inc's ROA has increased by 35% YoY but it has decreased by 4% from the previous quarter
The company's return on invested capital rose by 27% YoY but it fell by 4.8% QoQ

Dividends

DPS
$1.48
Dividend yield
4.29%
Payout ratio
52.1%

Recent dividends

Financial health

Assets vs liabilities
PFE's total assets is 65% greater than its total liabilities
The current ratio has contracted by 33% YoY but it has grown by 17% from the previous quarter
The quick ratio has grown by 20% from the previous quarter but it has contracted by 17% YoY
Debt vs equity
PFE's debt is 20% less than its equity
Pfizer Inc's equity has increased by 11% YoY and by 3% QoQ
The debt to equity has grown by 3.9% YoY but it has contracted by 3.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.